A supplement maker tried to silence this Harvard doctor — and put academic freedom on trial | STAT News
The dietary supplements had ominous names, like Black Widow and Yellow Scorpion. They contained an illegal and potentially dangerous molecule, similar in structure to amphetamines. But when a Harvard researcher dared to point that out, in a scientific, peer-reviewed study and in media interviews, the supplement maker sued him for libel and slander.
Venture funding for analytics, telemedicine, clinical surveillance heating up | Healthcare IT News
A recent spate of substantial venture investments are indicative of where the health industry is headed in 2017 and the years ahead, suggesting a burgeoning trend toward smarter data for clinical quality and value-based agility enabled by virtual care.
Donating Your Medical Data To Science | Huffington Post
One company that promises to advance this at a rapid rate is sequencing startup Genos. They promise to sequence your entire exome for $499, with a fascinating caveat.
The Latest Study On Breast Cancer Overdiagnosis Fails To Persuade | Forbes
Yesterday's health news delivered another paper slamming mammography. A report out of Denmark uses statistics to show that overdiagnosis is incredibly frequent. An accompanying editorial, by Dr. Otis Brawley of the American Cancer Society, is a call for acceptance by doctors of the overdiagnosis phenomenon.
